在摩洛哥的患者中,抗发作药物的坚持和手术的态度:一个横截面研究
El Bachir Hajji1, Boubacar Traore2,3, Samira Hassoune2,4
1Laboratory of Research on Neurologic, Neurosensorial Diseases and Disability, Faculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco.
Epilepsy & behavior reports
|May 21, 2024
概括
在摩洛哥患者中,不服抗药 (非AMA) 率为24.5%,手术 (ES) 拒绝率为33.3%. 与非AMA相关的因素包括男性性别和家族史,而ES拒绝与特定的型和药物组合有关.
科学领域:
- 神经学 神经学
- 公共卫生 公共卫生
- 药理学 药理学是指药理学的学科.
背景情况:
- 影响着全球数百万人,需要坚持抗药物 (AMA) 和考虑手术 (ES) 治疗.
- 了解不遵守AMA和对ES的态度对于优化患者 (PWE) 护理至关重要.
- 关于摩洛哥人口中这些因素的数据有限.
研究的目的:
- 为了确定非AMA和ES拒绝在摩洛哥PWE的流行程度.
- 确定与非AMA和ES拒绝相关的社会人口和临床因素.
主要方法:
- 从2021年12月到2022年12月进行了一项横截面研究,涉及294名摩洛哥成人PWE.
- 数据收集包括对AMA和ES态度的采访,以及对社会人口统计和临床信息的医疗档案的审查.
- 统计分析采用了奇平方测试和多变量逻辑回归 (p ≤0.05,95%CI).
主要成果:
- 在24.5%的PWE中观察到非AMA,冷漠是主要原因 (55.6%).
- 33.3%的PWE报告ES拒绝,主要是因为担心 (61.2%).
- 多变量分析揭示了男性性别和与非AMA相关的病家族史. 拒绝ES与全方位治疗使用,专注于焦点或普遍性以及通用和原始ASM的组合有关.
结论:
- 与其他研究相比,在摩洛哥PWE中观察到的非AMA和ES拒绝率相对较低.
- 这些发现可能反映了医疗保健工作人员对PWE治疗参与的提高意识.
- 进一步的研究可以探索具体的干预措施,以进一步改善坚持和外科接受.
相关概念视频
01:24Arteries of the Lower Limbs
188
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
188
01:08Antiepileptic Drugs: Sodium Channel Blockers
511
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
511
01:30Electroconvulsive Therapy
36
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
36
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
385
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
385
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
286
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
286
01:13Seizures: Classification
338
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
338